Biosenta Inc. News Releases

Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build

Thu, 11 Dec 2025 14:21:00 -0500

Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") On December 8, 2025 Biosenta has entered into a Field Test and Research Agreement with Livespace Homes to evaluate the real-world performance of Biosenta's proprietary antimicrobial nanoparticle technology in a residential construction environment. Under the agreement, the nanoparticles will be incorporated into building materials and/or coatings used in two (2) of the four (4)...

Former Canadian Coatings Association President & CEO Gary LeRoux joins Biosenta's Advisory Board

Wed, 01 Oct 2025 08:00:00 -0400

Veteran paint and coatings industry leader brings decades of executive and regulatory expertise to support commercialization of Tri-Filler(R) antimicrobial technology Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - October 1, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that Gary LeRoux, past President and CEO of the Canadian Coatings Association (CCA), has joined the company's advisory board.Gary LeRoux, CFA, joins Biosenta Inc. as strategic advisor. (CNW...

Veteran Finance Executive Tim Gillespie, CFA, Joins Biosenta as Strategic Advisor

Mon, 21 Jul 2025 17:00:00 -0400

Former ATB Financial executive vice-president brings more than 35 years of capital-markets and corporate-banking experience to accelerate Biosenta's growth Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - July 21, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that Tim Gillespie, CFA has joined the company as a strategic advisor. In this role, Mr. Gillespie will counsel Biosenta's executive team and board on financing, risk management and go-to-market strategy as the...

Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens at Industry-Low Dose in Peer-Reviewed Studies

Wed, 11 Jun 2025 13:15:00 -0400

Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - June 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that two independent, peer-reviewed studies conducted at the University of Calgary confirmed that its proprietary Tri-Filler™ core-shell calcium hydroxide-calcium carbonate (CSCC™) nanoparticles achieved complete (100 %)...

Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability

Mon, 10 Jun 2024 16:30:00 -0400

Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - June 10, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company"), a leader in developing eco-friendly antimicrobial compounds, is pleased to announce significant advancements at its state-of-the-art bench scale production facility, which have exceeded all expectations. These breakthroughs not only demonstrate the capability of the bench scale facility but also mark the beginning of preparations for a commercial scale production...

Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions

Wed, 08 May 2024 16:53:00 -0400

Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - May 8, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a strategic milestone, having entered into a license agreement (the "License Agreement") with 2581776 Ontario Inc. (dba Lightweight Concrete Solutions) ("Lightweight Concrete Solutions") pursuant to which Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta's Tri-Filler® technology in connection with certain specialty...

Biosenta Closes Private Placement Financing

Fri, 26 Apr 2024 19:20:00 -0400

Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has closed its private placement for gross proceeds of $600,000 (the "Offering"), as previously announced on April 19, 2024. Biosenta issued 1,500,000 units (each, a "Unit") under the Offering at a price of $0.40 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a "Common Share") and one half of one Common Share...

Biosenta Announces Private Placement Financing

Fri, 19 Apr 2024 17:59:00 -0400

Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a non-brokered private placement financing (the "Offering") of up 1,500,000 units of the Company (the "Units") at a price of $0.40 per Unit, for aggregate gross proceeds of up to $600,000.Each Unit will consist of one common share in the capital of the Company and one half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will...

Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology

Wed, 27 Mar 2024 12:25:00 -0400

Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - March 27, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a significant milestone in its technological and operational advancements with the successful construction and operation of a bench scale production plant. The results from this production not only surpassed our expectations, but also showcased that our patented Tri-Filler™ antimicrobial technology is ready for accelerated development and...

Amarvir Gill Holdings in Biosenta Inc.

Thu, 22 Feb 2024 13:20:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 22, 2024) - Amarvir Gill (the "Acquiror"), the President, Chief Executive Officer and a Director of Biosenta Inc. ("Biosenta") listed on the Canadian Securities Exchange (CSE: ZRO) announces that he acquired 1,250,000 common shares (the "Shares") and 625,000 warrants to purchase common shares (the "Warrants") pursuant to a debt settlement transaction whereby Biosenta issued the Shares 1,250,000 and 625,000 Warrants to settle $500,000 in debt owed to...